IDELVION albutrepenonacog alfa 3500 IU powder (and diluent) for injection

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

Factor IX, Quantity: 3500 IU

Prieinama:

CSL Behring Australia Pty Ltd

Vaisto forma:

Solution

Sudėtis:

Excipient Ingredients:

Vartojimo būdas:

Intravenous

Vienetai pakuotėje:

3500 IU

Recepto tipas:

Not scheduled. Not considered by committee

Terapinės indikacijos:

IDELVION is indicated in all patients with haemophilia B for:,? Routine prophylaxis to prevent or reduce the frequency of bleeding episodes,? Control and prevention of bleeding episodes,? Control and prevention of bleeding in the perioperative setting.

Produkto santrauka:

Visual Identification: Clear solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store between 2 - 25 degrees celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorizacija statusas:

Registered

Leidimo data:

2020-11-19